Large-scale testing (Phase 3)Looking for participantsNCT06881992What this trial is testingErsodetug in Patients With Tumor HyperinsulinismWho this might be right forTumor Hyperinsulinism (Tumor HI) Rezolute 16
Testing effectiveness (Phase 2)Ended earlyNCT04628481What this trial is testingOral Ladarixin in Recent Onset Type 1 Diabetes and a Low Residual β-cell FunctionWho this might be right forRecent Onset type1 Diabetes Dompé Farmaceutici S.p.A 289
Testing effectiveness (Phase 2)Looking for participantsNCT07552077What this trial is testingA Phase 2, Baseline-Controlled Study Evaluating the Safety and Efficacy of PTX-022 (Sirolimus) Topical Gel 3.9% in the Treatment of Angiokeratomas (LOTU)Who this might be right forAngiokeratomas Palvella Therapeutics, Inc. 15
Not applicableActive Not RecruitingNCT06862648What this trial is testingEvaluating SUI-100™, A Non-Invasive Device for the Treatment of Stress Urinary IncontinenceWho this might be right forStress Urinary Incontinence (SUI) Acoustic Wave Cell Therapy, Inc. 130
Large-scale testing (Phase 3)Active Not RecruitingNCT06239480What this trial is testingSELVA: A Phase 3 Study Evaluating QTORIN 3.9% Rapamycin Anhydrous Gel in the Treatment of Microcystic Lymphatic MalformationsWho this might be right forMicrocystic Lymphatic Malformation Palvella Therapeutics, Inc. 51
Testing effectiveness (Phase 2)Study completedNCT00001934What this trial is testingZenapax to Treat Multiple SclerosisWho this might be right forMultiple Sclerosis National Institute of Neurological Disorders and Stroke (NINDS) 22
Large-scale testing (Phase 3)Active Not RecruitingNCT05502341What this trial is testingStudy to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With a Complicated RegimenWho this might be right forHIV-1-infection Gilead Sciences 689
Testing effectiveness (Phase 2)Ended earlyNCT04899271What this trial is testingAssess Efficacy/Safety of Ladarixin in Type 1 Diabetes Patients With Preserved ß-cell Function at Baseline.Who this might be right forNew-onset Type 1 Diabetes Dompé Farmaceutici S.p.A 25
Large-scale testing (Phase 3)Study completedNCT02751931What this trial is testingOpen-label Phase 3 Study With Mirabegron in Children From 3 to Less Than 18 Years of Age With Neurogenic Detrusor OveractivityWho this might be right forNeurogenic Detrusor Overactivity Astellas Pharma Europe B.V. 91
Not applicableUnknownNCT06486935What this trial is testingCity For All Ages: Elderly-friendly City Services for Active and Healthy AgeingWho this might be right forBaseline/Control PhaseIntervention Phase National University of Singapore 19
Testing effectiveness (Phase 2)Study completedNCT01450124What this trial is testingSafety, Tolerability And Mechanism Of Action Of Boswellic Acids (BA) In Multiple Sclerosis (SABA)Who this might be right forRelapsing Remitting Multiple Sclerosis Universitätsklinikum Hamburg-Eppendorf 29
Testing effectiveness (Phase 2)Study completedNCT01494805What this trial is testingSafety and Efficacy Study of rAAV.sFlt-1 in Patients With Exudative Age-Related Macular DegenerationWho this might be right forMacular DegenerationAge-related MaculopathiesAge-related Maculopathy+5 more Lions Eye Institute, Perth, Western Australia 40
Large-scale testing (Phase 3)Looking for participantsNCT05491525What this trial is testingOpen-label, Long-term Safety, Efficacy, and Pharmacokinetics Study of Vibegron in Pediatric Subjects 2 Years to < 18 Years of Age With NDO and on CICWho this might be right forNeurogenic Detrusor Overactivity Urovant Sciences GmbH 71
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07712484What this trial is testingA Phase II Randomized Study to Evaluate Measures for Endpoint Derivation in Patients With Progressive or Refractory Disseminated Coccidioidomycosis Treated With Olorofim Plus Baseline Standard of Care or Placebo Plus Baseline Standard of CareWho this might be right forCoccidioidomycosisDisseminated Fungal InfectionCoccidioides Infection+5 more F2G Ltd 50
Large-scale testing (Phase 3)Study completedNCT01981954What this trial is testingA Clinical Study to Investigate How Solifenacin Fluid is Taken up, How Long it Stays in the Body and How Effective and Safe it is in Treating Children Aged From 6 Months to Less Than 5 Years With Symptoms of Neurogenic Detrusor Overactivity (NDO)Who this might be right forNeurogenic Detrusor OveractivityPediatric Astellas Pharma Europe B.V. 23
Large-scale testing (Phase 3)Study completedNCT02028884What this trial is testingEfficacy and Safety Study of Satralizumab (SA237) as Add-on Therapy to Treat Participants With Neuromyelitis Optica (NMO) and NMO Spectrum Disorder (NMOSD)Who this might be right forNeuromyelitis Optica (NMO)NMO Spectrum Disorder (NMOSD) Hoffmann-La Roche 85
Large-scale testing (Phase 3)Study completedNCT01642914What this trial is testingSafety and Efficacy of Linaclotide in Patients With Chronic Constipation and Prominent Abdominal BloatingWho this might be right forChronic ConstipationConstipation Forest Laboratories 487
Large-scale testing (Phase 3)Study completedNCT02435433What this trial is testingRamucirumab (LY3009806) Versus Placebo in Participants With Hepatocellular Carcinoma and Elevated Baseline Alpha-FetoproteinWho this might be right forHepatocellular Carcinoma Eli Lilly and Company 399
Large-scale testing (Phase 3)Study completedNCT01565694What this trial is testingAssess the Long Term Effect, Safety and Metabolism of a Solifenacin Liquid Suspension in Participants 5 to 18 Years of Age With Neurogenic Detrusor OveractivityWho this might be right forNeurogenic Detrusor Overactivity Astellas Pharma Europe B.V. 76
Post-approval studies (Phase 4)Study completedNCT00829244What this trial is testingCONSORT Randomized Controlled Trial in Assisted Reproductive TechnologyWho this might be right forInfertility Merck KGaA, Darmstadt, Germany 200